Table 1 Effect of drug combinations on SKOV-3 cell viability
Cell Viability [% of Untreated Control] | DOX [10 μM] | MMC [10 μM] | 4-HPR [5 μM] | 5-FU [1 mM] |
|---|---|---|---|---|
No TM | 70.7% | 73.0% | 83.1% | 78.3% |
With TM, 30 μM | 20.9% | 48.2% | 40.3% | 48.2% |
Cytotoxicity Increase | 2.5 fold | 1.6 fold | 2.9 fold | 1.9 fold |